Literature DB >> 8778319

p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters.

P Tenti1, R Zappatore, S Romagnoli, E Civardi, P Giunta, R Scelsi, G Stella, L Carnevali.   

Abstract

Seventy-nine transitional cell carcinomas (TCCs) of the urinary bladder (25 grade 1, 22 grade 2, and 32 grade 3 tumours) were examined for p53 overexpression by immunohistochemistry with a monoclonal antibody and for human papillomavirus (HPV) infection by the polymerase chain reaction (PCR). Positive immunostaining for p53 was detected in 40.5 per cent of the cases; the percentage of positive cases was significantly lower in low-grade (G1 and G2) TCCs than in high-grade (G3) tumours (10.6 per cent vs. 84.4 per cent; P < 0.0001). The overall rate of HPV infection was 32.9 per cent; 20.3 per cent of the cases were positive for HPV 16, 3.8 per cent for HPV 18, and 8.9 per cent for both. Consensus primers as well as type-specific primers for HPV types 6, 11, and 33 failed to detect any additional case with HPV infection. The prevalence of HPV 16 and/or HPV 18 infection was significantly higher in low-grade than in high-grade tumours (44.7 per cent vs. 15.6 per cent; P = 0.0061). p53-positive cases were more common among papillary, deeply infiltrating tumours, and HPV-positive cases among papillary, non-infiltrating lesions. According to these data, p53 overexpression and HPV 16/18 infection are common findings in bladder TCC and there appears to be an inverse correlation of p53 overexpression and of HPV infection with tumour aggressiveness. The possibility of different molecular pathways in superficial low-grade and in invasive high-grade tumours is suggested.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8778319     DOI: 10.1002/(SICI)1096-9896(199601)178:1<65::AID-PATH451>3.0.CO;2-W

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  7 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

2.  Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridisation.

Authors:  C De Gaetani; G Ferrari; E Righi; S Bettelli; M Migaldi; P Ferrari; G P Trentini
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

3.  Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors.

Authors:  Thanaa El A Helal; Mona T Fadel; Naglaa K El-Sayed
Journal:  Pathol Oncol Res       Date:  2006-09-23       Impact factor: 3.201

4.  Absence of human papillomavirus genomic sequences detected by the polymerase chain reaction in oesophageal and gastric carcinomas in Japan.

Authors:  M Saegusa; M Hashimura; Y Takano; M Ohbu; I Okayasu
Journal:  Mol Pathol       Date:  1997-04

5.  Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction.

Authors:  K W Chan; K Y Wong; G Srivastava
Journal:  J Clin Pathol       Date:  1997-12       Impact factor: 3.411

6.  Detection and typing of human papillomavirus DNA in paired urine and cervical scrapes.

Authors:  S Strauss; J Z Jordens; D McBride; C Sonnex; S Edwards; U Desselberger; P Watt; J J Gray
Journal:  Eur J Epidemiol       Date:  1999-07       Impact factor: 8.082

Review 7.  Prevalence of Human Papilloma Virus Infection in Bladder Cancer: A Systematic Review.

Authors:  Narcisa Muresu; Biagio Di Lorenzo; Laura Saderi; Illari Sechi; Arcadia Del Rio; Andrea Piana; Giovanni Sotgiu
Journal:  Diagnostics (Basel)       Date:  2022-07-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.